Leap Therapeutics Inc.

NASDAQ: LPTX · Real-Time Price · USD
0.42
0.03 (6.87%)
At close: Jun 09, 2025, 3:59 PM

Leap Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
32.71M 47.25M 62.82M 78.48M 54.92M 70.64M 80.74M 91.42M 102.04M 65.5M 78.31M 90.88M 103.22M 114.92M 124.77M 35.73M 43.49M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 505K 245K n/a n/a n/a n/a n/a n/a 610K 38K n/a 1.51M 309K 70K
Other Long-Term Assets
857K 823K 865K 859K 956K 966K 913K 1.5M 1.26M 1.71M 1.29M 721K 406K 383K 2.46M 1.36M 1.36M
Receivables
55K 704K 780K 754K 738K 771K 753K 2.05M 2.07M 2.1M 1.26M 1.13M 1.23M 1.19M 59K 22K 22K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.19M n/a n/a n/a
Other Current Assets
1.1M 86K 209K 354K 526K 183K 265K 419K 590K 351K n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
33.87M 48.04M 63.81M 79.59M 56.19M 71.6M 81.76M 93.88M 104.7M 67.95M 79.94M 92.44M 104.94M 116.87M 125.1M 36.02M 43.78M
Property-Plant & Equipment
152K 262K 370K 475K 577K 262K 372K 480K 585K 689K 791K 891K 387K 495K 354K 387K 489K
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -610K -38K n/a -1.51M -309K -70K
Total Long-Term Assets
1.01M 1.08M 1.24M 1.84M 1.78M 1.23M 1.28M 1.98M 1.85M 2.4M 2.23M 1.76M 957K 1.04M 2.98M 1.92M 2.03M
Total Assets
34.88M 49.12M 65.05M 81.43M 57.96M 72.83M 83.05M 95.86M 106.55M 70.35M 82.17M 94.2M 105.9M 117.91M 128.08M 37.94M 45.81M
Account Payables
6.36M 4.74M 5.95M 7.81M 5.95M 6.46M 5.9M 6.5M 5.5M 5.66M 6.28M 7.55M 4.29M 4.19M 7.97M 4.34M 3.51M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 375K 750K 1.13M
Short-Term Debt
154K 266K n/a 443K 430K 262K 369K 436K 425K 416K 405K 395K 363K 432K 323K 354K 418K
Other Current Liabilities
6.99M 8.8M 722K 4.53M 1.63M 2.51M 1.97M 2.75M 2.35M 2.21M 2.78M 805K 1.66M 2.25M 1.27M 2.36M 2.75M
Total Current Liabilities
14.04M 14.08M 16.09M 15.6M 10.44M 12.68M 11.04M 11.76M 10.31M 11.22M 11.72M 10.41M 7.34M 9.99M 11.26M 8.06M 7.39M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a 67.75M n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a 39K 154K n/a n/a 38K 67.91M 262K 369K 474K 4.65M 37K n/a n/a 36K
Total Liabilities
14.04M 14.08M 16.09M 15.64M 10.59M 12.68M 11.04M 11.8M 78.22M 11.49M 12.09M 10.88M 7.34M 10.02M 11.26M 8.06M 7.43M
Total Debt
154K 266K 376K 482K 584K 262K 369K 474K 577K 678K 774K 869K 363K 469K 323K 354K 454K
Common Stock
41K 38K 38K 38K 26K 26K 26K 26K 119K 99K 99K 88K 88K 88K 88K 60K 60K
Retained Earnings
-482.81M -467.37M -451.94M -433.76M -413.4M -399.58M -387.12M -373.42M -360.03M -318.17M -306.07M -290.97M -273.95M -263.57M -252.78M -241.65M -232.12M
Comprehensive Income
-113K -120K n/a 3K -120K 106K 760K 414K 355K 128K 690K 94K -425K -267K -246K -449K -564K
Shareholders Equity
20.84M 35.05M 48.95M 65.79M 47.37M 60.14M 72.01M 84.06M 28.33M 58.87M 70.07M 83.32M 98.56M 107.89M 116.82M 29.88M 38.38M
Total Investments
n/a n/a n/a 505K 245K n/a n/a n/a n/a n/a n/a 610K 38K n/a 1.51M 309K 70K